ScholarIQanswers from OpenAlex & ORCID
James P. Allison
ResearcherPublications, citations & collaboration network
James P. Allison is a researcher indexed in ScholarIQ from OpenAlex & ORCID.
How many works does James P. Allison have?
ScholarIQindexed works
James P. Allison has 1,234 works in the ScholarIQ index. The count is the OpenAlex total, not the number of papers listed on this page.
How many citations does James P. Allison have?
ScholarIQcitation count
James P. Allison has 121,679 citations in the OpenAlex counts ScholarIQ stores.
What is the h-index of James P. Allison?
ScholarIQh-index
James P. Allison has an h-index of 158 in OpenAlex.
What is the i10-index of James P. Allison?
ScholarIQi10-index
James P. Allison has an i10-index of 433 in OpenAlex.
What is the ORCID of James P. Allison?
ScholarIQorcid
The ORCID for James P. Allison is on the source record.
What is the OpenAlex record for James P. Allison?
ScholarIQopenalex
The OpenAlex for James P. Allison is on the source record.
What are the most-cited papers on James P. Allison?
ScholarIQmost cited works
Cancer regression and autoimmunity induced by cytotoxic T lymphocyte-associated antigen 4 blockade in patients with metastatic melanoma
Giao Q. Phan, James Chih‐Hsin Yang, Richard M. Sherry, Patrick Hwu, Suzanne L. Topalian, Douglas J. Schwartzentruber, Nicholas P. Restifo, Leah Haworth, Claudia A. Seipp, Linda J. Freezer, Kathleen E. Morton, Sharon Mavroukakis, Paul H. Duray, Seth M. Steinberg, James P. Allison, Thomas A. Davis, Steven A. Rosenberg
Distinct Cellular Mechanisms Underlie Anti-CTLA-4 and Anti-PD-1 Checkpoint Blockade
Spencer C. Wei, Jacob Levine, Alexandria P. Cogdill, Yang Zhao, Nana-Ama A.S. Anang, Miles C. Andrews, Padmanee Sharma, Jing Wang, Jennifer A. Wargo, Dana Pe’er, James P. Allison
Epithelial-to-mesenchymal transition induces cell cycle arrest and parenchymal damage in renal fibrosis
Sara Lovisa, Valerie S. LeBleu, Björn Tampe, Hikaru Sugimoto, Komal Vadnagara, Julienne L. Carstens, Chia-Chin Wu, Yohannes Hagos, Birgitta C. Burckhardt, Tsvetelina Pentcheva‐Hoang, Hersharan Nischal, James P. Allison, Michael Zeisberg, Raghu Kalluri
Co-occurring Genomic Alterations Define Major Subsets of <i>KRAS</i> -Mutant Lung Adenocarcinoma with Distinct Biology, Immune Profiles, and Therapeutic Vulnerabilities
Ferdinandos Skoulidis, Lauren A. Byers, Lixia Diao, Vassiliki A. Papadimitrakopoulou, Pan Tong, Julie Izzo, Carmen Behrens, Humam Kadara, Edwin R. Parra, Jaime Rodriguez Canales, Jianjun Zhang, Uma Giri, Jayanthi Gudikote, María Angélica Cortez, Chao Yang, You-Hong Fan, Michael Peyton, Luc Girard, Kevin R. Coombes, Carlo Toniatti, Timothy P. Heffernan, Murim Choi, Garrett M. Frampton, Vincent A. Miller, John N. Weinstein, Roy S. Herbst, Kwok‐Kin Wong, Jianhua Zhang, Padmanee Sharma, Gordon B. Mills, Waun Ki Hong, John D. Minna, James P. Allison, P. Andrew Futreal, Jing Wang, Ignacio I. Wistuba, John V. Heymach
Neoadjuvant immune checkpoint blockade in high-risk resectable melanoma
Rodabe N. Amaria, Sangeetha M. Reddy, Hussein A. Tawbi, Michael A. Davies, Merrick I. Ross, Isabella C. Glitza, Janice N. Cormier, Carol M. Lewis, Wen-Jen Hwu, Ehab Hanna, Adi Diab, Michael K. Wong, Richard E. Royal, Neil D. Gross, Randal S. Weber, Stephen Y. Lai, Richard A. Ehlers, Jorge Blando, Denái R. Milton, Scott E. Woodman, Robin Kageyama, Daniel K. Wells, Patrick Hwu, Sapna P. Patel, Anthony Lucci, Amy C. Hessel, Jeffrey E. Lee, Jeffrey E. Gershenwald, Lauren Simpson, Elizabeth M. Burton, Liberty Posada, Lauren E. Haydu, Linghua Wang, Shaojun Zhang, Alexander J. Lazar, Courtney W. Hudgens, Vancheswaran Gopalakrishnan, Alexandre Reuben, Miles C. Andrews, Christine N. Spencer, Víctor G. Prieto, Padmanee Sharma, James P. Allison, Michael T. Tetzlaff, Jennifer A. Wargo